#676
|
|||
|
|||
Îñìåëþñü ïðåäïîëîæèòü, ÷òî äëÿ ïðèíÿòèÿ âçâåøåííîãî ðåøåíèÿ òóò íàäî çíàòü äëÿ äàííîé ãðóïïû ïàöèåíòîâ number needed to treat, number needed to harm, è ñòîèìîñòü quality-adjusted life year. Ê ñîæàëåíèþ, ýòî íå ìîé óðîâåíü, îáðàçîâàíèÿ ìàëîâàòî, ïîýòîìó áóêâîåäñòâóþ ñ ãàéäàìè. Íî ó÷èòûâàÿ õîðîøóþ ïåðåíîñèìîñòü ñòàòèíîâ è íàëè÷èå íåäîðîãèõ äæåíåðèêîâ ÿ íàäåþñü, ÷òî â öåëîì áàëàíñ îò íàçíà÷åíèÿ òàêèì ìîèì ïàöèåíòàì ñòàòèíîâ âñ¸-òàêè ïîëîæèòåëüíûé.
|
#677
|
|||
|
|||
Áëÿøêà, êîòîðàÿ ìîæåò ðàçîðâàòüñÿ, ÷àùå âîîáùå íå áóäåò âûÿâëåíà íèêàêèìè ìåòîäàìè. Íî. åñëè ñëåäîâàòü Âàøåé ëîãèêå, òî íåîáõîäèìî áóäåò íàçíà÷àòü ñòàòèíû ïîæèçíåííî ñ äåòñàäîâñêîãî âîçðàñòà.
Îðèåíòèðóéòåñü íà SCORE. |
#678
|
|||
|
|||
Óâàæàåìûå êîëëåãè, ó ìåíÿ íå âîïðîñ, à ïðîñüáà. Íå ìîãëè áû âû ìíå ïîìî÷ü äîáûòü Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (ïîëíûé èëè executive summary) - ÷òîáû áûë è ñ îãëàâëåíèåì è îäíèì ôàéëîì. À òî âñ¸ ÷òî íàõîæó - ëèáî îäèí ôàéë áåç îãëàâëåíèÿ (î÷åíü íåóäîáíî èñêàòü íóæíîå), ëèáî êó÷åé îòäåëüíûõ ôàéëîâ (ïî 1 ôàéëó íà ãëàâó). Çàðàíåå áëàãîäàðåí.
|
#679
|
||||
|
||||
Öèòàòà:
9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Âåñü [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#680
|
|||
|
|||
Ñïàñèáî, íî ýòè âàðèàíòû åñòü. Ex. summary - íåò îãëàâëåíèÿ, òîëüêî ìèíèàòþðû ñòðàíèö, íå ïîìîãàþùèå ïîèñêó. Ññûëêà íà âåñü - ýòî ïî îòäåëüíîìó ïäô-ôàéëó íà êàæäóþ ãëàâó. Íî âñ¸ ðàâíî ñïàñèáî Ëàäíî, êàê-íèáóäü òàê ïðèñïîñîáëþñü.
|
#681
|
||||
|
||||
Öèòàòà:
|
#682
|
|||
|
|||
|
#683
|
|||
|
|||
Ïîäñêàæèòå ïîæàëóéñòà. Åñòü ïàöèåíòêà 87 ëåò, ïåðåíåñëà êðóïíîî÷àãîâûé èíôàðêò ïåðåäíåáîêîâîé ñ âåðõóøêîé â ìàå ýòîãî ãîäà, âûïèñàíà ñ ðåêîìåíäàöèÿìè êîðîíàðîãðàôèÿ-îïåðàöèÿ(íî îò ýòîãî îòêàç), ïðèíèìàëà òðîìáîàññ è êëîïèäîãðåëü 3 ìåñ, èìååò ïîñòîÿííóþ ôîðìó ÔÏ+ÕÑÍ 2Á. Êëîïèäîãðåëü îòìåíèëà â ñâÿçè ñ îêîí÷àíèåì ðåêîìåíäîâàííîãî ñðîêà-3 ìåñ.
Äóìàþ, îñòàâèòü åå íà òðîìáîàñå èëè âñå òàêè íàçíà÷èòü êñàðåëòî 15 ìã â ñóòêè ñ ó÷åòîì âîçðàñòà. ÌÍÎ êîíòðîëèðîâàòü íå ìîæåò. Ïåðåäâèãàåòñÿ â ïðåäåëàõ êâàðòèðû èç-çà îäûøêè, ñëàáîñòè. Èìååò òàêæå ëèìôîñòàç-ñëîíîâîñòü-ìíîãî ëåò. Ìàëîïîäâèæíà ñîîòâåñòâåííî. ÀÄ íèçêîå. Ïðèíèìàåò åùå äèãîêñèí, â áëîê, ëîçàï, âåðîøïèðîí, ôóðîñåìèä. |
#684
|
||||
|
||||
Äà, ðàçóìíî åå ïåðåâåñòè íà êñàðåëòî, îòìåíèâ àñïèðèí è êëîïè.
|
#685
|
|||
|
|||
Óâàæàåìûå êîëëåãè, ïîäñêàæèòå - åñòü ëè ãäå-òî ïðàêòè÷åñêîå ðóêîâîäñòâî èëè ÷òî-òî ïîäîáíîå ïî ëå÷åíèþ õðîíè÷åñêîé ðåâìàòè÷åñêîé áîëåçíè ñåðäöà (íå ïîðîêà, à ñàìîé õðáñ). Èíòåðåñóåò - ÷òî, êðîìå ÑÎÝ íàäî ñìîòðåòü â ïëàíå àêòèâíîñòè ïðîöåññà, êîãäà íàçíà÷àòü ÍÏÂÏ, àíòèáèîòèêè (è íàçíà÷àòü ëè âîîáùå), ñêîëüêî ïðîäîëæàòü òàêîå ëå÷åíèå, êîìó ïðîâîäèòü áèöèëëèíîïðîôèëàêòèêó (è íàäî ëè âîîáùå?) Çàðàíåå ñïàñèáî.
|
#686
|
|||
|
|||
Ïîñìîòðèòå ýòó òåìó.
http://forums.rusmedserv.com/showthr...E0%F2%E8%E7%EC
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#687
|
||||
|
||||
Öèòàòà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïîñëåäíÿÿ âåðñèÿ (2008, çäåñü ìîæíî ëåãêî ïîëó÷èòü ïåðåâîä â ãóãëüõðîìå) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Îðèãèíàë [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#688
|
|||
|
|||
Óâàæàåìûå êàðäèîëîãè, ïîìîãèòå ðàçîáðàòüñÿ. Âîïðîñ î ðåèíôàðêòå íà 5-å ñóòêè. Ðàçâå íà 5-å ñóòêè ãîâîðÿò î ðåèíôàðêòå?
Èñòî÷íèê: CASE FILES: Internal medicine third edition. Eugene C. Toy, John T.Patlan. Copyright © 2009. A 59-year-old diabetic woman had suffered an acute anterior wall MI.Five days later, she gets into an argument with her husband and complains of chest pain. Her initial ECG shows no ischemic changes, but serum cardiac troponin I levels are drawn and return mildly elevated at this time. Which of the following is the best next step? A. Thrombolytic therapy. B. Percutaneous coronary intervention. C. Coronary artery bypass. D. Perform serial ECGs and obtain CK-MB. E. Prepare the patient for dialysis. ANSWER D. Diabetic patients can have myocardial ischemia or infarction with atypical or absent symptoms. Clinical suspicion is required, and a liberal use of cardiac enzymes. Troponin levels often remain elevated for 7 to 10 days and should not be used to diagnose reinfarction, especially if the levels are trending downward. New ECG findings or rapidly rising markers such as serum myoglobin or CK-MB can be used in this setting. ß íàøëà òîëüêî ýòó ñòàòüþ, http://medgazeta.rusmedserv.com/2003...ticle_305.html íî òàì î ñðîêàõ êîêðåòíî íå ãîâîðèòñÿ.
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#689
|
|||
|
|||
Âîò ÷òî ïî ýòîìó ïîâîäó ñêàçàíî â [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Recurrent Myocardial Infarction: ‘Incident MI’ is defined as the individual’s first MI. When features of MI occur in the first 28 days after an incident event, this is not counted as a new event for epidemiological purposes. If characteristics of MI occur after 28 days following an incident MI, it is considered to be a recurrent MI. Reinfarction: The term ‘reinfarction’ is used for an acute MI that occurs within 28 days of an incident- or recurrent MI. Òî åñòü, íàñêîëüêî ÿ ïîíèìàþ recurrent ñîîòâåòñòâóåò íàøåìó "ïîâòîðíîìó" , à reinfarction - ðåöèäèâó ÈÌ |
#690
|
||||
|
||||
Öèòàòà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |